China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- Foreign delegates gain a close look at grassroots livelihood, protection of people's rights
- Primary school students tell revolutionary stories of Jinggangshan in English
- Shanxi emergency official probed after deadly mine blast
- One hundred thirty-six artifacts from Cambodia on display in Shanxi
- Hukou Waterfall roars to life after heavy upstream rainfall
- Lion King co-director heads jury at Chongqing animation festival
